Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...

Sanofi's amlitelimab confirms its potential in atopic dermatitis In the SHORE phase 3 study, amlitelimab in combination with topical therapies met all primary and key secondary endpoints at Week ...

A pair of bills limiting the use of cellphones in classrooms received near-unanimous support in the Michigan Senate.

The International Society for Stem Cell Research (ISSCR) today announced the upcoming release of "Charting the Translational ...

MITOLINE Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory Metabolic Diseases - A Market Projected to Exceed $120 billion by 2030 Neve ...

Sync your drop-down menus with table headers using this robust, auto-expanding Named Range trick.

The global transplant diagnostics market, valued at USD 3.9 billion in 2021, is anticipated to grow at a CAGR of 7.40%, reaching approximately USD 6.4 billion by 2028. This growth is driven by ...

Zepto Life Technology has announced the launch of the FungiFlex® Mold Panel, a plasma-based molecular diagnostic test now ...

New immune roadmaps help physicians detect cancer recurrence early and customize treatments to the body’s defenses, providing ...

Microsoft's spreadsheet program can do way more than you might imagine. These are the hacks and tricks you need to know.

Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential ...

Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...